BIRC5 and nasopharyngeal carcinoma: The Immunoblotting data showed that treatment of MG132, a proteasome inhibitor, restored the protein level of survivin in Butein-treated NPC cells (Fig. 3A,B), indicating that Butein might affect the stability of survivin protein.